Breve 14: Mexico's Coordinating Commission for Negotiating the Price of Medicines and Other Health Inputs
This Breve gives an overview of the characteristics of the pharmaceutical sector in Mexico and the main factors resulting in the decision to establish the CCPNM. It briefly discusses the legal framework of the Commission. Then, it looks at the CCPNM's objective and operations, before describingthe negotiation process. The results of the CCPNM in economic and organizational terms, as well as other positive impacts, are analyzed in the subsequent section. Finally, the Breve concludes by presenting some of the challenges emerging from the Mexican experience with its price negotiation scheme.